EUVIMEDEUVIMED entdecken
Kohortenstudie

Cardiometabolic Outcomes after Surgical Remission of Endogenous Hypercortisolism: A Prospective Cohort Study

Shireen R Chacko iD, Shubhangi Sharma Sharma, Sarina Ahmadian, Jasmine Saini, Vanessa Fell, Anina F Peersen, Elizabeth J Atkinson, Lucinda Gruber iD, Jamie J Van Gompel iD, Vinaya Simha iD, William F Young, Irina Bancos iD

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgaf693 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Shireen R Chacko und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN 55905, USA. Hauptthemen laut MEDLINE: Cushing Syndrome, Diabetes Mellitus, Cardiovascular Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Cushing syndrome.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Evidence on the evolution of cardiometabolic comorbidities following surgical remission of hypercortisolism is scarce.

Objective

To determine the impact of surgical remission on cardiometabolic comorbidities in patients with endogenous hypercortisolism and to identify factors associated with cardiometabolic improvement.

Methods

Prospective single-center cohort study (2019-2025) of adults with Cushing syndrome (CS) or mild autonomous cortisol secretion (MACS) with surgical remission of hypercortisolism. Outcomes included (1) changes in severity of hypertension, diabetes mellitus (DM), hyperlipidemia, and obesity between baseline, 3, and 12 months postremission and (2) factors associated with improvement in comorbidities.

Results

Among 357 patients (49% MACS, 36% pituitary CS, 10% adrenal CS, 5% ectopic CS; median age 53 years [interquartile range 42-62]; 81% women), 336 (94%) had hypertension, 241 (68%) had obesity, and 122 (35%) had DM. At a median of 12 months postsurgery, improvement in hypertension occurred in 70% (90/128) of patients with CS and 51% (60/117) of patients with MACS, DM in 90% (46/51) patients with CS and 37% (13/35) patients with MACS, and obesity in 79% (77/97) patients with CS and 20% (14/71) patients with MACS. In a multivariable analysis, higher baseline biochemical severity scores were associated with improvement in hypertension [odds ratio (OR) 1.3, 95% confidence interval (CI) 1.1-1.5), DM (OR 2.5, 95% CI 1.7-4.1), and obesity (OR 1.5, 95% CI 1.2-1.8) at a median of 12 months postremission of hypercortisolism.

Conclusion

Postsurgical improvement of cardiometabolic comorbidities was observed in both patients with CS and MACS. Higher baseline biochemical severity scores were associated with higher postremission improvement in comorbidities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cushing SyndromeDiabetes MellitusCardiovascular DiseasesHumansFemaleMaleMiddle AgedProspective StudiesAdultHypertensionComorbidityObesityHydrocortisoneRemission InductionTreatment OutcomeHyperlipidemias

Stichwörter der Autor:innen

Cushing syndromeMACSPROMISE studydiabetes mellitushypertensionobesity

Substanzen

Hydrocortisone

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN 55905, USA.
  • Department of Internal Medicine, Yale New Haven Hospital, New Haven, CT 06510, USA.
  • Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA.
  • Department of Neurosurgery, Mayo Clinic, Rochester, MN 55905, USA.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.

ORCID-Profile: Shireen R Chacko, Lucinda Gruber, Jamie J Van Gompel, Vinaya Simha, Irina Bancos

Förderung

  • Cushing syndrome

Zitieren

APA

Chacko, S. R., Sharma, S. S., Ahmadian, S., Saini, J., Fell, V., Peersen, A. F., Atkinson, E. J., Gruber, L., Van Gompel, J. J., Simha, V., Young, W. F., & Bancos, I. (2026). Cardiometabolic Outcomes after Surgical Remission of Endogenous Hypercortisolism: A Prospective Cohort Study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf693

Vancouver

Chacko SR, Sharma SS, Ahmadian S, Saini J, Fell V, Peersen AF, et al. Cardiometabolic Outcomes after Surgical Remission of Endogenous Hypercortisolism: A Prospective Cohort Study. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf693

BibTeX
@article{Chacko2026,
  author = {Chacko, Shireen R and Sharma, Shubhangi Sharma and Ahmadian, Sarina and Saini, Jasmine and Fell, Vanessa and Peersen, Anina F and Atkinson, Elizabeth J and Gruber, Lucinda and Van Gompel, Jamie J and Simha, Vinaya and Young, William F and Bancos, Irina},
  title = {Cardiometabolic Outcomes after Surgical Remission of Endogenous Hypercortisolism: A Prospective Cohort Study},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgaf693}
}
Kostenlos starten →